News

Should You Buy Johnson & Johnson Stock Before July 16th?
Johnson & Johnson ( JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most ...
Philanthropists Lauder, Abraham and Johnson left legacies worthy of emulation | Editorial
The three philanthropists devoted themselves and their resources to important causes during lifetimes of service to Palm ...
Johnson & Johnson Q2 Preview: Focus on tariff threat, MedTech softness
Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.
Johnson & Johnson's Outlook Clouded By $2 Billion Headwind
Johnson & Johnson's 2025 outlook sees slight EPS and revenue upgrades, while headwinds from biosimilars and tariffs are expected to weigh on performance.
Johnson & Johnson (JNJ) Declined Amid Broad Sell-Off in Healthcare
Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Premier Strategy” ...
Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data
Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced ...